human β endorphin elisa kit (Assay Genie)
Structured Review

Human β Endorphin Elisa Kit, supplied by Assay Genie, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+%CE%B2+endorphin+elisa+kit/bio_rxiv__64898__2026__02__25__707676-162-12-17?v=Assay+Genie
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "The Endocannabinoid System’s Contribution to Placebo Analgesia"
Article Title: The Endocannabinoid System’s Contribution to Placebo Analgesia
Journal: bioRxiv
doi: 10.64898/2026.02.25.707676
Figure Legend Snippet: To investigate the contribution of eCB and β-endorphin, and their interaction to placebo analgesia, we used a validated placebo paradigm. (A) First, to determine individual stimulus intensities and stimulation sites, we applied an adaptive staircase calibration procedure for thermal heat pain. At the beginning of the placebo paradigm, participants were informed that they would be receiving two creams during the procedure: a highly potent experimental analgesic cream, and a control cream. In reality, both creams provided were Vaseline (petroleum jelly, Vaseline Healing Jelly Original, Unilever). Red lines and drops indicate blood sampling. Next, participants underwent three blocks of testing (B): a manipulation block followed by two test blocks (conditions: placebo, control), counterbalanced across participants. Blood was drawn before and after each block. In the manipulation block, participants received individually calibrated heat stimuli to elicit a rating of 8/10 to control cream sites, and 4/10 to placebo cream sites. This manipulation served to condition participants and bolster expectations. For the next two blocks, participants received heat stimuli calibrated to elicit a 6/10, either on the control cream sites, or on the ‘analgesic’ cream sites, depending on the block (placebo, control). (C) Each block of stimulation consisted of twelve trials. At the end of each trial, participants provided a pain intensity rating. Panel B was made using Biorender.
Techniques Used: Cream, Control, Sampling, Blocking Assay
Figure Legend Snippet: (A) Ratings plotted at low circulating β-endorphin levels (-1 SD). Participants with higher FAAH analyte values (+1 SD) reported increased placebo analgesia, reflected in lower pain ratings in the placebo condition relative to control. ( B) Ratings plotted at mean circulating β-endorphin levels. Higher FAAH analyte values (+1 SD) were associated with reduced pain ratings under placebo compared to control. (C) Ratings plotted at high circulating β-endorphin levels (+1 SD). Minimal relationship between FAAH analyte values and placebo analgesia. Error bars represent ±1 SE.
Techniques Used: Control
